Outlook Therapeutics
OTLK
OTLK
66 hedge funds and large institutions have $44.7M invested in Outlook Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.87% less ownership
Funds ownership: 36.28% → 35.41% (-0.87%)
29% less capital invested
Capital invested by funds: $62.7M → $44.7M (-$17.9M)
Holders
66
Holding in Top 10
–
Calls
$1.64M
Puts
$84K
Top Buyers
| 1 | +$2.04M | |
| 2 | +$1.65M | |
| 3 | +$603K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$488K |
| 5 |
ACM
Altium Capital Management
New York
|
+$212K |
Top Sellers
| 1 | -$2.18M | |
| 2 | -$1.82M | |
| 3 | -$968K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$843K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$484K |